PER 5.00% 10.5¢ percheron therapeutics limited

Chart, page-1851

  1. 35,750 Posts.
    lightbulb Created with Sketch. 554
    I don't think they need $50M for EU trial alone but i think $20-$30M would put them in a strong position .... might need more in time but it's a good balance - at least start with $10M but really even that's just dragging it out plodding a long.

    People go on about other companies for comparison OPT, NEU, PYC etc etc

    How do their cash balances & cash to MC stand up ?

    Also worth noting though with cash and any company without revenue - it will come down to how much you are spending, cash is fleeting and regardless of balance it is always going to be diminishing so will often end up holding greater than 10% cash.

    Last thing i think anybody wants to see is them deal it out here with $4M CAB - 99% chance it would come back looking like every other deal before it imo.

    I like the old boat analogy when it comes to cash position -

    You can plod a long with the canoe, paddling your heart out with your oar, open to the elements - and in the end if you're fit enough and the weather is good you will get there.

    Or you can have a bigger boat, with a engine, roof over your head and you'll cruise along to your destination.

    One option gets you there fast the other option ... takes a while .... but you still get there .. maybe ... is it too late though ?

    Then it comes to the deal - how much do you pay for a ride on the canoe ? how about the boat ?

    The last 2 deals they've paddled in on the canoe
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.